SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-264805
Filing Date
2020-10-06
Accepted
2020-10-06 16:45:19
Documents
3
Period of Report
2020-10-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d17368d8k.htm 8-K 27197
2 EX-99.1 d17368dex991.htm EX-99.1 8403
3 EX-99.2 d17368dex992.htm EX-99.2 8258
  Complete submission text file 0001193125-20-264805.txt   44999
Mailing Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000
Business Address LEVEL 14, 114 WILLIAM ST MELBOURNE, VIC C3 3000 61(0)3 8692-7222
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 201227223
SIC: 2834 Pharmaceutical Preparations